CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and…
Category: Insights
Gravie Secures $28 Million in Financing Led by AXA Venture Partners
Gravie, the pioneer of defined contribution healthcare, today announced that they have raised $28 million in a Series…
Loopback Analytics and Cone Health Partner on Specialty Pharmacy and Value-Based Care Initiatives
Loopback Analytics, a leader in population health analytics, is excited to announce its partnership with Cone…
Scanning Electron Microscope Market to Grow by USD 463.60 Million during 2021-2025|Increasing Focus on Nanotechnology to Boost Market |Technavio
The global scanning electron microscope market is expected to grow by USD 463.60 million during 2021-2025, as per…
Employer Direct Healthcare Announces Partnership with Dole Food Company
Employer Direct Healthcare (EDH) is excited to announce its new partnership with Dole Food Company. On January…
Global Digital POCT (Point-of-Care Testing) Market 2020-2025: Mobility Ecosystem Holds Bold Promise to Expand Patients Access to Care
The “Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Market” report has been added…
LogicBio Therapeutics Reports Full Year 2020 Financial Results and Provides Business Update
LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio or the Company), a clinical- stage genetic medicine company pioneering gene…
Global $8.1B Parkinson’s Disease Drugs Market Outlook to 2027 – Impact of COVID-19 and Profiles of Key Players Including AbbVie,
Global Parkinson’s Disease Drugs Market to Reach $8.1 Billion by 2027 Amid the COVID-19 crisis, the global market…
Worldwide Nephrology Devices Industry to 2025 – Rising Awareness about the Benefits of Nephrological Devices Presents Opportunities
The “Global Nephrology Devices Market (2020-2025) by Device Type, End User And Geography, Impact of Covid-19, Ansoff…
NeuroBo Pharmaceuticals to Participate in H.C. Wainwright Global Life Sciences Conference
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that Company management will participate in the…